These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 21808028)

  • 1. Reversal of muscle insulin resistance with exercise reduces postprandial hepatic de novo lipogenesis in insulin resistant individuals.
    Rabøl R; Petersen KF; Dufour S; Flannery C; Shulman GI
    Proc Natl Acad Sci U S A; 2011 Aug; 108(33):13705-9. PubMed ID: 21808028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skeletal muscle insulin resistance promotes increased hepatic de novo lipogenesis, hyperlipidemia, and hepatic steatosis in the elderly.
    Flannery C; Dufour S; Rabøl R; Shulman GI; Petersen KF
    Diabetes; 2012 Nov; 61(11):2711-7. PubMed ID: 22829450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome.
    Petersen KF; Dufour S; Savage DB; Bilz S; Solomon G; Yonemitsu S; Cline GW; Befroy D; Zemany L; Kahn BB; Papademetris X; Rothman DL; Shulman GI
    Proc Natl Acad Sci U S A; 2007 Jul; 104(31):12587-94. PubMed ID: 17640906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of muscle insulin resistance in the pathogenesis of atherogenic dyslipidemia and nonalcoholic fatty liver disease associated with the metabolic syndrome.
    Jornayvaz FR; Samuel VT; Shulman GI
    Annu Rev Nutr; 2010 Aug; 30():273-90. PubMed ID: 20645852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postprandial de novo lipogenesis and metabolic changes induced by a high-carbohydrate, low-fat meal in lean and overweight men.
    Marques-Lopes I; Ansorena D; Astiasaran I; Forga L; Martínez JA
    Am J Clin Nutr; 2001 Feb; 73(2):253-61. PubMed ID: 11157321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease.
    Smith GI; Shankaran M; Yoshino M; Schweitzer GG; Chondronikola M; Beals JW; Okunade AL; Patterson BW; Nyangau E; Field T; Sirlin CB; Talukdar S; Hellerstein MK; Klein S
    J Clin Invest; 2020 Mar; 130(3):1453-1460. PubMed ID: 31805015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized 3-way crossover study indicates that high-protein feeding induces de novo lipogenesis in healthy humans.
    Charidemou E; Ashmore T; Li X; McNally BD; West JA; Liggi S; Harvey M; Orford E; Griffin JL
    JCI Insight; 2019 Jun; 4(12):. PubMed ID: 31145699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease.
    Lambert JE; Ramos-Roman MA; Browning JD; Parks EJ
    Gastroenterology; 2014 Mar; 146(3):726-35. PubMed ID: 24316260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fructose as a key player in the development of fatty liver disease.
    Basaranoglu M; Basaranoglu G; Sabuncu T; Sentürk H
    World J Gastroenterol; 2013 Feb; 19(8):1166-72. PubMed ID: 23482247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease.
    Zhao L; Cang Z; Sun H; Nie X; Wang N; Lu Y
    BMC Endocr Disord; 2017 Feb; 17(1):13. PubMed ID: 28241817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time course of postprandial hepatic phosphorus metabolites in lean, obese, and type 2 diabetes patients.
    Fritsch M; Koliaki C; Livingstone R; Phielix E; Bierwagen A; Meisinger M; Jelenik T; Strassburger K; Zimmermann S; Brockmann K; Wolff C; Hwang JH; Szendroedi J; Roden M
    Am J Clin Nutr; 2015 Nov; 102(5):1051-8. PubMed ID: 26423389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The adipokine sFRP4 induces insulin resistance and lipogenesis in the liver.
    Hörbelt T; Knebel B; Fahlbusch P; Barbosa D; de Wiza DH; Van de Velde F; Van Nieuwenhove Y; Lapauw B; Thoresen GH; Al-Hasani H; Müller-Wieland D; Ouwens DM; Kotzka J
    Biochim Biophys Acta Mol Basis Dis; 2019 Oct; 1865(10):2671-2684. PubMed ID: 31336149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fructose overconsumption causes dyslipidemia and ectopic lipid deposition in healthy subjects with and without a family history of type 2 diabetes.
    Lê KA; Ith M; Kreis R; Faeh D; Bortolotti M; Tran C; Boesch C; Tappy L
    Am J Clin Nutr; 2009 Jun; 89(6):1760-5. PubMed ID: 19403641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-time assessment of postprandial fat storage in liver and skeletal muscle in health and type 2 diabetes.
    Ravikumar B; Carey PE; Snaar JE; Deelchand DK; Cook DB; Neely RD; English PT; Firbank MJ; Morris PG; Taylor R
    Am J Physiol Endocrinol Metab; 2005 Apr; 288(4):E789-97. PubMed ID: 15572652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrahepatic Fat and Postprandial Glycemia Increase After Consumption of a Diet Enriched in Saturated Fat Compared With Free Sugars.
    Parry SA; Rosqvist F; Mozes FE; Cornfield T; Hutchinson M; Piche ME; Hülsmeier AJ; Hornemann T; Dyson P; Hodson L
    Diabetes Care; 2020 May; 43(5):1134-1141. PubMed ID: 32165444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease.
    Kawano Y; Cohen DE
    J Gastroenterol; 2013 Apr; 48(4):434-41. PubMed ID: 23397118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonalcoholic fatty liver disease is associated with hepatic and skeletal muscle insulin resistance in overweight adolescents.
    Deivanayagam S; Mohammed BS; Vitola BE; Naguib GH; Keshen TH; Kirk EP; Klein S
    Am J Clin Nutr; 2008 Aug; 88(2):257-62. PubMed ID: 18689359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic lipogenesis and a marker of hepatic lipid oxidation, predict postprandial responses of triglyceride-rich lipoproteins.
    Matikainen N; Adiels M; Söderlund S; Stennabb S; Ahola T; Hakkarainen A; Borén J; Taskinen MR
    Obesity (Silver Spring); 2014 Aug; 22(8):1854-9. PubMed ID: 24890344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Docosahexaenoic acid enrichment in NAFLD is associated with improvements in hepatic metabolism and hepatic insulin sensitivity: a pilot study.
    Hodson L; Bhatia L; Scorletti E; Smith DE; Jackson NC; Shojaee-Moradie F; Umpleby M; Calder PC; Byrne CD
    Eur J Clin Nutr; 2017 Aug; 71(8):973-979. PubMed ID: 28294174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal pattern of de novo lipogenesis in the postprandial state in healthy men.
    Timlin MT; Parks EJ
    Am J Clin Nutr; 2005 Jan; 81(1):35-42. PubMed ID: 15640457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.